Jessica McNeil1. 1. Department of Kinesiology, School of Health and Human Sciences, University of North Carolina Greensboro, 351D Coleman Building, 1408 Walker avenue, Greensboro, NC, 27412-5020, USA. jnmcneil2@uncg.edu.
Abstract
PURPOSE: The study of energy balance [i.e., energy intake (EI) and energy expenditure (EE)] is a powerful tool for understanding body weight regulation and may contribute to our understanding of rapid weight gain risk in certain cancer survivors post-diagnosis. The purpose of this review was to summarize studies that assessed longitudinal, prospective changes in components of energy balance from diagnosis/start of treatment to any duration of follow-up in cancer survivors with prior evidence of weight gain (breast, prostate, thyroid, gynecologic, testicular, and acute lymphoblastic leukemia) RESULTS: The available literature suggests that energy balance components may be altered in cancer survivors who have a heightened risk of weight gain post-diagnosis. The evidence for EI was overall inconsistent. Conversely, decreases in resting and physical activity EE during the active phases of treatment (e.g., chemotherapy, hypothyroid state) were commonly noted, which then slowly rebounded towards baseline levels at the end of treatment and during follow-up assessments. Much of this evidence is based on data collected from breast cancer survivors, which highlights a paucity of data currently available on other cancer types. CONCLUSIONS: While there is growing acknowledgement that weight management interventions in cancer survivors are needed, it is important to recognize that changes in both behavioral (EI, physical activity EE) and passive (resting EE, thermic effect of food) components of energy balance may occur post-diagnosis. This information can help to inform weight management interventions which often entail modifications in diet and/or physical activity.
PURPOSE: The study of energy balance [i.e., energy intake (EI) and energy expenditure (EE)] is a powerful tool for understanding body weight regulation and may contribute to our understanding of rapid weight gain risk in certain cancer survivors post-diagnosis. The purpose of this review was to summarize studies that assessed longitudinal, prospective changes in components of energy balance from diagnosis/start of treatment to any duration of follow-up in cancer survivors with prior evidence of weight gain (breast, prostate, thyroid, gynecologic, testicular, and acute lymphoblastic leukemia) RESULTS: The available literature suggests that energy balance components may be altered in cancer survivors who have a heightened risk of weight gain post-diagnosis. The evidence for EI was overall inconsistent. Conversely, decreases in resting and physical activity EE during the active phases of treatment (e.g., chemotherapy, hypothyroid state) were commonly noted, which then slowly rebounded towards baseline levels at the end of treatment and during follow-up assessments. Much of this evidence is based on data collected from breast cancer survivors, which highlights a paucity of data currently available on other cancer types. CONCLUSIONS: While there is growing acknowledgement that weight management interventions in cancer survivors are needed, it is important to recognize that changes in both behavioral (EI, physical activity EE) and passive (resting EE, thermic effect of food) components of energy balance may occur post-diagnosis. This information can help to inform weight management interventions which often entail modifications in diet and/or physical activity.
Authors: Patrick T Bradshaw; Joseph G Ibrahim; June Stevens; Rebecca Cleveland; Page E Abrahamson; Jessie A Satia; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon Journal: Epidemiology Date: 2012-03 Impact factor: 4.822
Authors: Nikola S Mutschler; Christoph Scholz; Thomas W P Friedl; Thomas Zwingers; Peter A Fasching; Matthias W Beckmann; Tanja Fehm; Svjetlana Mohrmann; Jessica Salmen; Carola Ziegler; Bernadette Jäger; Peter Widschwendter; Nikolaus de Gregorio; Fabienne Schochter; Sven Mahner; Nadia Harbeck; Tobias Weissenbacher; Julia Jückstock; Wolfgang Janni; Brigitte Rack Journal: Clin Breast Cancer Date: 2018-01-31 Impact factor: 3.225
Authors: Bette J Caan; Marilyn L Kwan; Xiao Ou Shu; John P Pierce; Ruth E Patterson; Sarah J Nechuta; Elizabeth M Poole; Candyce H Kroenke; Erin K Weltzien; Shirley W Flatt; Charles P Quesenberry; Michelle D Holmes; Wendy Y Chen Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-06-13 Impact factor: 4.254
Authors: Hazel B Nichols; Amy Trentham-Dietz; Kathleen M Egan; Linda Titus-Ernstoff; Michelle D Holmes; Andrew J Bersch; Crystal N Holick; John M Hampton; Meir J Stampfer; Walter C Willett; Polly A Newcomb Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-04-14 Impact factor: 4.254
Authors: Sarah Nechuta; Wendy Y Chen; Hui Cai; Elizabeth M Poole; Marilyn L Kwan; Shirley W Flatt; Ruth E Patterson; John P Pierce; Bette J Caan; Xiao Ou Shu Journal: Int J Cancer Date: 2015-12-09 Impact factor: 7.396
Authors: Koji Matsuo; Aida Moeini; Sigita S Cahoon; Hiroko Machida; Marcia A Ciccone; Brendan H Grubbs; Laila I Muderspach Journal: Ann Surg Oncol Date: 2016-04-25 Impact factor: 5.344
Authors: Gustavo Schvartsman; Angelica M Gutierrez-Barrera; Juhee Song; Naoto T Ueno; Susan K Peterson; Banu Arun Journal: Cancer Med Date: 2017-10-10 Impact factor: 4.452